| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/27/2006 | WO2006043691A1 Target protein and target gene in drug designing and screening method |
| 04/27/2006 | WO2006043148A1 Process for producing enantiomer of amlodipine in high optical purity |
| 04/27/2006 | WO2006043064A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | WO2006012256A3 Fkbp binding composition and pharmaceutical use thereof |
| 04/27/2006 | WO2005121086A3 Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| 04/27/2006 | WO2005069834A3 4-aryl piperidines |
| 04/27/2006 | WO2005054871A3 Analysis of mass spectral data in the quiet zones |
| 04/27/2006 | US20060089383 Substituted piperidine compounds and methods of their use |
| 04/27/2006 | US20060089368 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/26/2006 | EP1650189A1 Benzylamine derivative |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648868A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 04/26/2006 | EP1648458A1 2-'4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamine derivtives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 04/26/2006 | CN1764659A Prostaglandin analogs as EP4 receptor antagonists |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1763007A 4-acetoxypiperidine hydrochlorate preparation method |
| 04/26/2006 | CN1253554C acidophilic bacteria strain with nitrile hydrolase activity |
| 04/26/2006 | CN1253436C Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034158 Method of producing biperiden I |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034041 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine |
| 04/25/2006 | US7034020 inactivators of antigen-specific T cells; increased half-life |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006041381A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 04/20/2006 | WO2006041204A1 Anti-graying preparation |
| 04/20/2006 | WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040156A1 Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines |
| 04/20/2006 | WO2006040155A1 Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| 04/20/2006 | WO2005117882A8 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 04/20/2006 | US20060084808 Dehydrating a piperidine carboxamide with thionyl chloride; one step process; chemical intermediates in antidepressants, anti-inflammatory and immunomodulators |
| 04/20/2006 | US20060084807 Novel denzamide derivatives and process for production thereof |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084662 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | CA2584833A1 Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines |
| 04/20/2006 | CA2584831A1 Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| 04/20/2006 | CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2582933A1 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/20/2006 | CA2582640A1 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/19/2006 | EP1647274A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1646620A1 Substituted piperidines as histamine h3 receptor ligands |
| 04/19/2006 | EP1476427A4 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 04/19/2006 | EP1363883B1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 04/19/2006 | EP1258477B1 Resolution of the enantiomers of amlodipine |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761652A Cathepsin S inhibitors |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/18/2006 | US7030247 Method for the production of biperidin |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030145 or anxiety; {3-[4-(2-Methoxybenzyloxy)-benzenesulfonyl]-6-methylpyridin-2-yl}-(4-methoxy-2-methylphenyl)-amine for example |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030115 Anticancer agents; autoimmune diseases; antiinflammatory agents |
| 04/18/2006 | CA2205230C N-hydroxypiperidines as superoxide radicals scavengers |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079559 S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079558 R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
| 04/13/2006 | US20060079557 Sulfamoyl benzamide derivatives and methods of their use |
| 04/13/2006 | US20060079555 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/13/2006 | US20060079554 Inhibitors of monomine uptake |
| 04/13/2006 | US20060079484 Antithrombotic effect |
| 04/13/2006 | DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers |
| 04/12/2006 | EP1644347A1 N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT sb 2C /sb RECEPTOR ASSOCIATED DISEASES |
| 04/12/2006 | EP1644345A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 04/12/2006 | EP1644334A1 Antithrombotic ethers |
| 04/12/2006 | EP1644329A1 Hydrogen peroxide catalyzed process for the preparation of sterically hindered n-hydrocarbyloxyamines |
| 04/12/2006 | EP1644326A1 Cathepsin cysteine protease inhibitors |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1542988B1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1075261B1 Mycobacterial inhibitors |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0912179B1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 04/12/2006 | CN1759108A Biphenyl derivatives |
| 04/12/2006 | CN1758909A Substituted piperidines as novel MDM2-p53 inhibitors |
| 04/12/2006 | CN1250626C Candle wax stabilized by combination of UV absorber plus selected hindered amine |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |